Download:
pdf |
pdfOMB No. 0990-0379
Exp. Date 09/30/2020
Opioid Prescribing Presentation PreAssessment
Start of Block: Default Question Block
Introduction: The purpose of this study is to research best practices for pain education
curricula, develop an evidence-based curriculum focusing on improving opiate prescribing for
women, and create core competencies for opioid prescription education for the School of
Osteopathic Medicine of Rowan University. In order to continuously improve upon opioid
education, this questionnaire was developed to measure provider knowledge and attitudes. This
is not a performance based test, it is simply to gauge practitioner impressions of identifying
where further education should be directed. Please answer honestly to the best of your ability.
Instructions: Please answer the following questions #1-10 to the best of your ability.
1. Which of the following are the most appropriate pharmacologic treatments for opioid
dependence?
o Acamprosate.
o Disulfiram.
o Buprenorphine.
o Naloxone.
According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of
information unless it displays a valid OMB control number. The valid OMB control number for this information
collection is 0990-0379 . The time required to complete this information collection is estimated to average 5 minutes
per response, including the time to review instructions, search existing data resources, gather the data needed, to
review and complete the information collection. If you have comments concerning the accuracy of the time
estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services,
OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports
Clearance Officer
Page 1 of 17
2. Which of the following is the most appropriate approach to maintaining sobriety for opioid
addiction?
o Abstinence-based approach with counseling.
o Opioid replacement therapy with counseling (i.e. Methadone or Suboxone).
o Behavior modification therapy.
o Motivational interviewing based counseling.
3. Buprenorphine works most appropriately as a(n):
o Full opioid agonist.
o Partial opioid agonist.
o Opioid antagonist.
o Combination opioid agonist/antagonist.
4. Naltrexone can be administered by the following method:
o Intravenous (IV).
o Intramuscular (IM).
o Intranasally.
o All of the above.
Page 2 of 17
5. According to the FDA, for which of the following conditions are extended release/long-acting
(ER/LA) opioids indicated?
o Severe consistent pain at the end of life.
o Episodic migraine pain.
o Cancer breakthrough pain.
o None of the above.
6. Which of the following are most likely to be true of female patients?
o Females have lower utilization of healthcare and physician visits.
o Females have a higher mortality rate from opioid overdose compared to men.
o Females experience and report pain more frequently compared to men.
o All of the above.
7. Please read the following scenario and answer to the best of your ability.
Two female patients present with dull or achy pain in the lower back. Upon assessment, there
appears to be no definitive cause.
The first patient, a non-Hispanic white middle-class woman, is being treated with
benzodiazepines and extended release oxycodone for her chronic back pain. She has private
insurance and complains that the prescribed medication is not enough. The second patient, a
non-Hispanic black low-income woman with Medicaid, is being treated with metformin for her
diabetes, but her primary care physician has declined to treat her with long-term opioid
medication.
Both patients want opioid treatment. You continue the same dose for the first patient and start
the second patient on low-dose, long acting opioids. Assuming both live in Camden County,
Page 3 of 17
which patient is most at risk for engaging in heroin use?
o The first patient.
o Both patients.
o The second patient.
o Neither patient.
8. When providing obstetric care to women, which of the following approaches to care is most
appropriate?
o
It is best practice in obstetric care to focus drug screenings based on factors such as
poor adherence to prenatal care and history of prior adverse pregnancy outcome.
o
It is recommended for the patient to undergo medically supervised withdrawal to avoid
any risks to the fetus when treating pregnant women with opioid use disorder.
o
Pregnant women with an opioid use disorder are prone to high relapse rates and it is
preferable to treat patients with opioid agonist pharmacotherapy.
o
Providers should only use Screening Brief Intervention and Referral to Treatment
(SBIRT) when a pregnant female patient is suspected of opiate use disorder.
9. When providing clinical care to breastfeeding women, the most appropriate recommendation
should be:
o To discourage women from breastfeeding if taking an opioid agonist.
o To encourage women to breastfeed if taking an opioid agonist.
o To provide pros & cons of breastfeeding while on opioid agonists.
o To assess for risk of relapse while on opioid agonists.
Page 4 of 17
10. Before prescribing opioids for non-pregnant female patients, the most appropriate next step
for health care providers is to:
o Ensure that there is no family medical history of opioid dependence or abuse.
o
Discuss the risks and benefits of opioid use and check vital signs for patient' pain
intensity.
o
Take a thorough history of substance use and use formal screening tools with patients at
risk.
o
Discuss family planning and duration of opioid use effects on the body with reproductiveaged female patients.
Page 5 of 17
Instructions: Please indicate your level of agreement with the statements listed.
Page 6 of 17
Currently in my practice…
Page 7 of 17
Strongly
Disagree
Disagree
Neither
Agree nor
Disagree
Agree
Strongly
Agree
I trust that
most of my
patients with
chronic pain
are able to
provide an
accurate selfassessment
of their pain.
o
o
o
o
o
I trust that
available pain
scales
provide
reliable
assessment
of pain.
o
o
o
o
o
Female
patients are
less likely to
be compliant
in pain
management
than male
patients.
o
o
o
o
o
I look forward
to treating
chronic pain
patients in my
practice.
o
o
o
o
o
It is very
difficult to feel
satisfied with
the treatment
outcomes of
most chronic
pain patients.
o
o
o
o
o
More men
than women
who receive
opiates
subsequently
become
addicts.
o
o
o
o
o
Page 8 of 17
Prescribing
opioids is a
high risk
clinical
activity for a
primary care
physician.
o
o
o
o
o
Page Break
Page 9 of 17
Instructions: Please indicate your level of agreement with the statements listed.
Page 10 of 17
Currently in my practice…
Page 11 of 17
Strongly
Disagree
Disagree
Neither
Agree nor
Disagree
Agree
Strongly
Agree
I understand
general
strategies on
how to
implement
patient
prescriber
agreements.
o
o
o
o
o
I able to
educate my
patient about
proper
storage and
disposal of
extendedrelease/longacting
(ER/LA)
opioids.
o
o
o
o
o
I counsel
about the risk
of overdose.
o
o
o
o
o
I counsel
about the
particular
risks
associated
with female
patients when
prescribing
opioid
analgesics.
o
o
o
o
o
I explain to
my patient
the methods I
use to
monitor
opioid misuse
(urine drug
tests and/or
pill counts).
o
o
o
o
o
Page 12 of 17
I understand
how to read a
urine drug
screen.
o
o
o
o
o
I understand
how to obtain
information
on state and
federal
requirements
for
prescribing
opioids.
o
o
o
o
o
I know how to
calculate
conversion
doses of
commonly
used opioids.
o
o
o
o
o
Page Break
Page 13 of 17
Instructions: Please indicate your level of agreement with the statements listed in #1-10.
Page 14 of 17
Currently in my practice I...
Page 15 of 17
Strongly
Disagree
Disagree
Neither
Agree nor
Disagree
Agree
Strongly
Agree
I am
comfortable
in responding
to family calls
about my
patients’
possible
misuse of
opioids.
o
o
o
o
o
I feel
prepared to
diagnose
addiction.
o
o
o
o
o
I am
confident that
I am
personally
skilled in
treating
chronic pain.
o
o
o
o
o
I am familiar
with general
strategies for
providers
prescribing
opioid
medications
that help
decrease the
risk of
misuse.
o
o
o
o
o
I know how to
refer a
patient with
an addiction.
o
o
o
o
o
Page 16 of 17
I know how to
distinguish
requests for
increased
medication
for untreated
pain versus
requests for
increased
medication
because of
an underlying
addiction
disorder.
o
o
o
o
o
Page Break
Page 17 of 17
| File Type | application/pdf |
| File Modified | 2018-07-16 |
| File Created | 2018-07-16 |